SenesTech, which is commercializing a non-lethal rodent control chemical that lowers rat fertility, announced terms for its IPO on Thursday.
The Flagstaff, AZ-based company plans to raise $26 million by offering 2.0 million shares at a price range of $12 to $14. At the midpoint of the proposed range, SenesTech would command a fully diluted market value of $152 million.
SenesTech was founded in 2004 and plans to list on the Nasdaq under the symbol SNES. Roth Capital is the sole bookrunner on the deal. It has not disclosed a pricing date.
